Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Measurement of the double- \(\varvec{\beta }\) decay of \(\varvec{^{150}}\) Nd to the 0 \(\varvec{^+_1}\) excited state of \(\varvec{^{150}}\) Sm in NEMO-3

    The NEMO-3 results for the double- \(\beta \) β decay of

    X. Aguerre, R. Arnold, C. Augier, A. S. Barabash in The European Physical Journal C (2023)

  2. Article

    Open Access

    A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial

    Baricitinib is supposed to have a double effect on SARS-CoV2 infection. Firstly, it reduces the inflammatory response through the inhibition of the Januse-Kinase signalling transducer and activator of transcri...

    G. Moreno-González, A. Mussetti, A. Albasanz-Puig, I. Salvador, A. Sureda in Trials (2021)

  3. Article

    Open Access

    Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    In this update of the consensus of the Spanish Society of Medical Oncology (Sociedad Española de Oncología Médica—SEOM) and the Spanish Society of Pathology (Sociedad Española de Anatomía Patológica—SEAP), adv...

    P. García-Alfonso, R. García-Carbonero in Clinical and Translational Oncology (2020)

  4. No Access

    Article

    Increased survival time or better quality of life? Trade-off between benefits and adverse events in the systemic treatment of cancer

    Primary objective of the study was to assess the relative weighting between benefit in survival time (SV), benefit in quality of life (QoL) and willingness to experience adverse events (AEs), in patient prefer...

    V. Valentí, J. Ramos, C. Pérez, L. Capdevila in Clinical and Translational Oncology (2020)

  5. Article

    Open Access

    Detailed studies of \(^{100}\) Mo two-neutrino double beta decay in NEMO-3

    The full data set of the NEMO-3 experiment has been used to measure the half-life of the two-neutrino double beta decay of \(^{100}\) ...

    R. Arnold, C. Augier, A. S. Barabash in The European Physical Journal C (2019)

  6. Article

    Open Access

    Final results on \({}^\mathbf{82 }{\hbox {Se}}\) double beta decay to the ground state of \({}^\mathbf{82 }{\hbox {Kr}}\) from the NEMO-3 experiment

    Using data from the NEMO-3 experiment, we have measured the two-neutrino double beta decay ( \(2\nu \beta \beta \) ...

    R. Arnold, C. Augier, A. S. Barabash in The European Physical Journal C (2018)

  7. No Access

    Article

    Translational research in neuroendocrine tumors: pitfalls and opportunities

    Interest in research on neuroendocrine tumors (NETs) has grown in the past 10 years, coinciding with improvements in our understanding of the molecular pathogenesis of NETs. In addition, NETs have become one o...

    J Capdevila, O Casanovas, R Salazar, D Castellano, A Segura, P Fuster, J Aller in Oncogene (2017)

  8. Article

    Open Access

    Gate-Controlled WSe2 Transistors Using a Buried Triple-Gate Structure

    In the present paper, we show tungsten diselenide (WSe2) devices that can be tuned to operate as n-type and p-type field-effect transistors (FETs) as well as band-to-band tunnel transistors on the same flake. Sou...

    M. R. Müller, R. Salazar, S. Fathipour, H. Xu, K. Kallis in Nanoscale Research Letters (2016)

  9. No Access

    Article

    Exact Energy Computation of the One Component Plasma on a Sphere for Even Values of the Coupling Parameter

    The two dimensional one component plasma 2dOCP is a classical system consisting of N identical particles with the same charge q confined in a two dimensional surface with a neutralizing background. The Boltzmann ...

    R. Salazar, G. Téllez in Journal of Statistical Physics (2016)

  10. No Access

    Article

    Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei)

    The epithelial appendiceal neoplasms are uncommon and are usually detected as an unexpected surgical finding. The general surgeon should be aware of the diversity of its clinical manifestations and biological ...

    P. Barrios, F. Losa, S. Gonzalez-Moreno, A. Rojo in Clinical and Translational Oncology (2016)

  11. Article

    Open Access

    SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015

    Colorectal cancer (CRC) is the second leading cause of cancer dead in Spain. About half the patients will eventually develop distant metastases. However, as treatment options are expanding, prognosis has stead...

    E. Aranda, J. Aparicio, V. Alonso, X. Garcia-Albeniz in Clinical and Translational Oncology (2015)

  12. No Access

    Article

    Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Publication of this consensus statement is a joint initiative of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM), intended to revise and update the diagnostic and tre...

    P. García-Alfonso, J. García-Foncillas, R. Salazar in Clinical and Translational Oncology (2015)

  13. No Access

    Article

    Pancreatic NETs: where do we stand now?

    The systemic management of patients with pancreatic neuroendocrine tumors includes chemotherapy and targeted agents such as everolimus and sunitinib. Which treatment to favor in a particular patient is not kno...

    S. Faivre, D. Castellano, J. Strosberg, E. González in Cancer and Metastasis Reviews (2014)

  14. No Access

    Article

    Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin

    Peritoneal carcinomatosis (PC) is a common form of tumour metastasis stemming from gastrointestinal and colorectal cancers. For a long time, PC has been considered a terminal clinical condition treated only wi...

    F. Losa, P. Barrios, R. Salazar, J. Torres-Melero in Clinical and Translational Oncology (2014)

  15. No Access

    Article

    Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors

    Kahalalide F (KF) is a dehydroaminobutyric acid-containing peptide from marine origin with activity against several human malignant cell lines. This dose-escalating phase I clinical trial evaluated the maximum...

    R. Salazar, H. Cortés-Funes, E. Casado, B. Pardo in Cancer Chemotherapy and Pharmacology (2013)

  16. No Access

    Article

    A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer

    Background This phase I, open-label, dose-escalation study examined the safety, maximum tolerated dose (MTD), and pharmacokinetics of sunitinib plus chemotherapy in patients with advanced gastric...

    C. Gómez-Martín, R. Salazar, C. Montagut, M. Gil-Martín in Investigational New Drugs (2013)

  17. No Access

    Article

    Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors

    Background ES-285 (spisulosine) is a novel compound derived from the marine mollusk Spisula polynoma with evidence of preclinical antitumor activity. This phase I clinical trial was designed to i...

    C. Massard, R. Salazar, J. P. Armand, M. Majem, E. Deutsch in Investigational New Drugs (2012)

  18. No Access

    Article

    A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors

    To determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), and recommended phase II dose (RD) of elisidepsin.

    R. Salazar, R. J. Jones, A. Oaknin, D. Crawford in Cancer Chemotherapy and Pharmacology (2012)

  19. No Access

    Article

    Mineralization of Triadimefon Fungicide in Water by Electro-Fenton and Photo Electro-Fenton

    The complete mineralization of the conazole fungicide triadimefon in water at pH 3 using electrochemical advanced oxidation processes, electro-Fenton and photo electro-Fenton, was achieved. The electrochemical...

    R. Salazar, M. S. Ureta-Zañartu in Water, Air, & Soil Pollution (2012)

  20. No Access

    Article

    Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy

    Menopausal hormone therapy (MHT) is associated with an increased breast cancer risk in postmenopausal women, with combined estrogen–progestagen therapy posing a greater risk than estrogen monotherapy. However,...

    R. Hein, S. Abbas, P. Seibold, R. Salazar in Breast Cancer Research and Treatment (2012)

previous disabled Page of 3